Posted on 8/2/16
12 Big Pharma Stats That Will Blow You Away
IMAGE SOURCE: GETTY IMAGES.It only makes sense that Big Pharma would be associated with some big numbers. The size and reach of the major biopharmaceutical companies . . .
Posted on 8/2/16
SciFluor Life Sciences Enters Clinical Trial Stage for Novel Treatment for Retinal Diseases
CAMBRIDGE, Mass.--(BUSINESS WIRE)--SciFluor Life Sciences, Inc., a clinical stage biopharmaceutical company developing a portfolio of therapeutic drugs capitalizing on the transformational power of fluorine, today announced . . .
Posted on 8/2/16
Enumeral Announces Sale of 12% Senior Secured Promissory Notes
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB:ENUM), a biotechnology company focused on the discovery and development of novel antibody-based immunotherapies to help the immune system fight . . .
Posted on 8/2/16
Inotek Pharmaceuticals Announces Public Offering of $50 Million Notes
LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) has commenced an underwritten public offering of $50 million aggregate principal amount of Convertible Senior Notes due 2021 (the “Notes”), . . .
Posted on 8/2/16
Bridgemedica and Alcresta Therapeutics Honored as Gold Winners in the 2016 Medical Design Excellence Award
MANSFIELD, Mass.--(BUSINESS WIRE)--Bridgemedicatoday announced that RELiZORB™ has been selected as theGold Winner in the Over-the-Counter and Self-Carecategory of the 18th Annual Medical Design Excellence Awards competition. . . .
Posted on 8/2/16
McKesson Health Solutions Awarded Patent for Healthcare Provider Management Technology
NEWTON, Mass. & KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--The United States Patent and Trademark Office has awarded U.S. Patent No. 9,269,117 to McKesson Health Solutions for proprietary . . .
Posted on 8/1/16
Selecta Biosciences Announces Publication in Nature Nanotechnology
Published results from preclinical studies show the potential of Selecta’s proprietary SVP-Rapamycin (SEL-110) immune therapy to improve the efficacy and safety of biologic therapeutics The data . . .
Posted on 8/1/16
Tokai Pharmaceuticals Announces Reduction in Force
BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced . . .
Posted on 8/1/16
12 Big Pharma Stats That Will Blow You Away
IMAGE SOURCE: GETTY IMAGES.It only makes sense that Big Pharma would be associated with some big numbers. The size and reach of the major biopharmaceutical companies . . .
Posted on 8/1/16
Akcea Therapeutics Receives Orphan Designation in Europe
Akcea Therapeutics, a wholly-owned subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced today that the European Commission (EC) has designated volanesorsen as an orphan medicinal product . . .
Posted on 8/1/16
CVS Health to Increase Access to FDA-approved Nasal Naloxone for Patients without Insurance
CVS Health (NYSE: CVS) and Adapt Pharma (www.AdaptPharma.com) today announced a new partnership that will make the opioid overdose-reversing drug NARCAN® (Naloxone HCl) Nasal Spray more . . .
Posted on 7/31/16
Tokai Pharmaceuticals Announces Reduction in Force
BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced . . .
Posted on 7/31/16
Southcoast Autism Center Expands
?Southcoast Autism Center, an intensive Applied Behavior Analysis center for children and families affected by Autism, will open
Posted on 7/29/16
Alexion Reports Second Quarter 2016 Results
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the second quarter of 2016. Total revenues grew to $753 million, an 18 . . .
Posted on 7/29/16
RELiZORB Recognized for Medical Design Excellence
Alcresta Therapeutics, Inc. (Alcresta), a company focused on developing innovative enzyme-based products for gastrointestinal and rare diseases, today announced that RELiZORB was selected as the Gold . . .
Posted on 7/28/16
Alkermes Reports Second Quarter 2016 Financial Results
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for the second quarter of 2016. “Our second quarter results demonstrate the power of our business model . . .
Posted on 7/27/16
Anika Reports Second Quarter 2016 Financial Results
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today reported . . .
Posted on 7/27/16
Vertex Reports Second Quarter 2016 Financial Results
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the quarter ended June 30, 2016 and reviewed recent progress with its approved and . . .
Posted on 7/27/16
IMS Health Reports Second-Quarter 2016 Results
DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced results for . . .
Posted on 7/27/16
Kevin Bernard, MD Joins New England Baptist Hospital
Kevin Bernard, MD has joined New England Baptist Hospital, a Boston-based premier regional provider for orthopedic surgery
Posted on 7/27/16
Avitide to Expand Affinity Separation Discovery and Manufacturing Operations
LEBANON, N.H.--(BUSINESS WIRE)--Avitide, Inc., a biotech company dedicated to the discovery, manufacture, and supply of on-demand affinity purification solutions for the biopharmaceutical industry, announced that it . . .
Posted on 7/27/16
Cynosure Reports Net Income of $6.3 Million for Q2 2016
Cynosure, Inc. (NASDAQ: CYNO) today reported second-quarter 2016 net income of $6.3 million, or $0.27 per diluted share, an increase of 18.3 percent compared with$5.4 million, . . .
Posted on 7/26/16
Psychemedics Corp. Announces Record Revenues And Earnings
Psychemedics Corporation (NASDAQ: PMD) today announced second quarter financial results for the period ended June 30, 2016. The Company also announced a quarterly dividend of $0.15 . . .
Posted on 7/26/16
Tokai Pharmaceuticals Announces Clinical Update
BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that . . .
Posted on 7/26/16
Moderna Therapeutics Provides Mid-Year Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics™ to create a new generation of transformative medicines for patients, . . .
Boston
